FREE EDUCATIONAL WEBINAR
10 February 2026, 15:00 - 15:45 PM CET (*)
AI is beginning to find its place in BD&L. While adoption varies across companies, many BD teams are already experimenting with AI to speed up search, landscape monitoring and early-stage analysis. Yet questions remain about where AI truly adds value and where traditional methods still outperform the technology.
Join CELforPharma faculty member Dr Carlos Velez for this 45-minute educational webinar.
What you'll learn:
How AI is being applied — unevenly but increasingly — across BD workflows
Practical AI use cases for in-licensing: search, monitoring, due diligence
How AI can support out-licensing: partner identification, conference prep, negotiation readiness
Examples of tools and approaches BD teams are trying today
Key risks, limitations and common pitfalls
About the expert:
Dr Carlos Velez, expert trainer of Business Development & Licensing Course For Pharma & Biotech, is a seasoned expert in pharma and biotech business development and licensing.
Founder and Managing Partner of Lacerta Bio, an international consultancy specialising in in- and out-licensing of prescription and non-prescription product candidates and commercial products across multiple therapeutic areas and markets.
Over 10 years in senior business development roles at Penwest Pharmaceuticals, Lantic Therapeutics, Forest Labs, and Genencor (now Danisco).
Author of Partnering for Growth – Business Development and Licensing in Pharma and Biotech (2025), a comprehensive guide reflecting his extensive industry insights.
Highly experienced trainer and consultant who is consistently praised by participants for his excellent didactic approach and his ability to draw from his vast experience in business development and licensing.
(*) If you cannot attend the webinar, please note that a recorded playback will be sent to all registrants after the webinar.